Atlas Trials

Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery

Clinical trial NCT00769145 · COMPLETED

Trial details

NCT number
NCT00769145
Sponsor
University of Miami
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Corneal Neovascularization
Start date
2008-10-01
Primary completion
2011-08-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.